For the Inventor, By the Inventor

Enter assignee name

Chapel Hill, NC, United States of America

Cardioxyl Pharmaceuticals, Inc.

USPTO Granted Patents = 37

EPO Patents = 14

Forward Citations = 395

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Vincent Jacob Kalish (37 out of 52 patents)

Frederick Arthur Brookfield (37 out of 64 patents)

Stephen Martin Courtney (37 out of 52 patents)

4. Lisa Marie Frost (37 out of 37 patents)

5. John P Toscano (31 out of 42 patents)

6. Andrew D Cohen (14 out of 14 patents)

7. John Reardon (3 out of 3 patents)

8. Carl Leslie North (2 out of 6 patents)

9. Art Sutton (2 out of 2 patents)

10. Daryl A Guthrie (1 out of 6 patents)

11. Matthew Robert Conroy (1 out of 1 patent)

12. Reza Mazhari (8 patents)

37 patents: Sort by Forward Citations

1. 12186301 - Nitroxyl donors with improved therapeutic index (2025-01-07),

2. 11786501 - Nitroxyl donors with improved therapeutic index (2023-10-17),

3. 11306056 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2022-04-19),

4. 11304924 - Pharmaceutical compositions comprising nitroxyl donors (2022-04-19),

5. 11273143 - Nitroxyl donors with improved therapeutic index (2022-03-15),

6. 10829445 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2020-11-10),

7. 10792273 - Nitroxyl donors with improved therapeutic index (2020-10-06),

8. 10730828 - N-hydroxylsulfonamide derivatives as nitroxyl donors (2020-08-04),

9. 10723704 - Pyrazolone derivatives as nitroxyl donors (2020-07-28),

10. 10548872 - Pharmaceutical compositions comprising nitroxyl donors (2020-02-04),

11. 10517847 - Nitroxyl donors with improved therapeutic index (2019-12-31),

12. 10487049 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2019-11-26),

13. 10245249 - Pharmaceutical compositions comprising nitroxyl donors (2019-04-02),

14. 10213408 - Nitroxyl donors with improved therapeutic index (2019-02-26),

15. 10179765 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors (2019-01-15),

Cardioxyl Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development of novel therapeutic treatments for cardiovascular diseases. With a focus on harnessing the power of nitric oxide to address unmet medical needs, Cardioxyl is dedicated to advancing innovative solutions for patients. By combining expertise in medicinal chemistry, drug discovery, and clinical development, the company aims to bring forth transformative cardiovascular drugs to improve the lives of individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

37 Patents

#2 in Chapel Hill, NC

#207 in North Carolina

#8,947 in US

#17,724 in the World

Chapel Hill, NC, United States of America

Cardioxyl Pharmaceuticals, Inc.

Forward Citations = 395

11 inventors:

Vincent Jacob Kalish (37 out of 52 patents)

Frederick Arthur Brookfield (37 out of 64 patents)

Stephen Martin Courtney (37 out of 52 patents)

4. Lisa Marie Frost (37 out of 37 patents)

5. John P Toscano (31 out of 42 patents)

Please report any incorrect information to support@idiyas.com

Loading…